Tekla Life Sciences Investors Price (HQL)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

28,058,046

(0.8339)%

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of sm... Read More

Sector: Financial Services

  • Previous Close Fetching Data...
  • Range $12.69-15.9
  • Market Cap 354.46M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Asset Management

  • ceo: Dr. Daniel R. Omstead M.S, Ph.D.
  • IPO Date: May, 01, 1992
  • Country: US
  • Currency: USD
  • Headquaters: Boston, MA
  • Employees: No Data

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation